LEAH TEICHMILLER: Open Payments
NPI 1710433529 · MATTOON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 37 payments from 11 companies in 2025. Trend: 2023 $314 · 2024 $619 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $298 |
| Eisai Inc. | 3 | $86 |
| UCB, Inc. | 3 | $60 |
| Merz Pharmaceuticals, LLC | 1 | $35 |
| SK Life Science, Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $25 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Biogen, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: UBRELVY, BOTOX, Leqembi, QULIPTA, Xeomin, KISUNLA, Briviact, Fintepla.
Industry payments across IL — which companies pay providers there.
